3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Endocrine
1
Conditions
Colorectal Neoplasms
9
Breast Neoplasms
7
Uterine Cervical Neoplasms
6
Neoplasms
5
Lung Neoplasms
4
Colonic Neoplasms
4
Rectal Neoplasms
2
Prostatic Neoplasms
2
Patient Compliance
2
Papillomavirus Infections
2
Liver Neoplasms
2
Colorectal Cancer Screening
2
Carcinoma, Hepatocellular
2
Tobacco Use
1
Smoking
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma
1
Liver Diseases
1
Hypertension
1
Hepatitis C
1
Hematopoietic and Lymphatic System Neoplasm
1
Head and Neck Neoplasms
1
Depression
1
Communication
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
ColoRectal Cancer Screening
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Interventions
relacorilant
4
Hydrochlorothiazide
4
Nutrition Assessment
3
Labetalol
2
Bevacizumab
2
Angiotensin-Converting Enzyme Inhibitors
2
Amlodipine
2
ziprasidone
1
sacubitril and valsartan sodium hydrate drug combination
1
pembrolizumab
1
fimasartan
1
enzalutamide
1
clevidipine
1
cediranib
1
bicalutamide
1
aliskiren
1
Zolpidem
1
Warfarin
1
Vitamin D
1
Vecuronium Bromide
1
Vancomycin
1
Tumor Necrosis Factors
1
Tranexamic Acid
1
Tobramycin
1
Thiazides
1
Therapeutics
1
Surveys and Questionnaires
1
Sunitinib
1
Sulindac
1
Spironolactone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Hypertension
×
Patient Navigation
×
Clear all
NCT01092078
2015-04-22
MISTER-B
NYU Langone Health
Phase NA
Completed
740 enrolled